Federal award
INO THERAPEUTICS LLC
HT940623F0133
Contract
Obligated and Ceiling
- Obligated (net)
- $379,698.00
- Ceiling (potential value, not spending)
- $512,930.00
- Current value
- $290,774.00
- Gross positive obligations
- $379,698.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- INO THERAPEUTICS LLC · XXQHL619FUN6
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- INO THERAPEUTICS LLC · XXQHL619FUN6
- Awarding agency
- Department of War · sub-agency 97DH · office HT9406
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- HT940623F0133
- Parent vehicle (IDV PIID)
- V797D60737
- Award type code
- C
- Actions
- 7 · Aug 31, 2023 to Dec 16, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History7
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Dec 16, 2025 | FY2026 | P00006 | B | $85,602.00 | — |
| Sep 15, 2025 | FY2025 | P00005 | G | $88,924.00 | — |
| Nov 27, 2024 | FY2025 | P00004 | C | $102,586.00 | — |
| Sep 20, 2024 | FY2024 | P00003 | G | $0.00 | — |
| Mar 12, 2024 | FY2024 | P00002 | M | $16,984.00 | — |
| Dec 21, 2023 | FY2024 | P00001 | C | $85,602.00 | — |
| Aug 31, 2023 | FY2023 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.